Shows / TheBrief.Health
Episodes
- TheBrief.Health
Cost-Effectiveness of Point-of-Care HCV RNA Testing in US
Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As…
- TheBrief.Health
CYP2C19 Genetic Testing Guides Personalized Blood Thinner Therapy
CYP2C19 genetic testing is emerging as a practical tool to tailor antiplatelet therapy for people who need blood thinners after a heart attack, stent…
- TheBrief.Health
Warfarin Self-Management in U.S. Health Care: Nonrandomized Trial
Warfarin self-management empowers patients to monitor INR and adjust dosing, improving control and outcomes while reducing clinic burden, though requiring…
- TheBrief.Health
Why Some Men May Struggle to Open Up Emotionally
Men’s mental health is often overlooked due to stigma around emotional expression, delaying support and increasing risk of crisis, highlighting need for…
- TheBrief.Health
FDA recommends guidance Revision Over Dialysis System Tubing Concern
The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe…
- TheBrief.Health
Surgeons Drive Momentum for Robotics in Acute Care Settings
Robotic-assisted surgeries, led by da Vinci Surgical System, are expanding rapidly, improving efficiency, outcomes, and competition while driving adoption…
- TheBrief.Health
Cerebral Oximetry’s Impact on Oxygenation in Preterm Infants
Monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, improve survival, guide NICU care, and support…
- TheBrief.Health
Extending Mental Health Interventions Beyond Therapy Settings
Digital tools, wearables, and AI extend therapy beyond sessions, enabling real-time support, earlier intervention, and personalized care, while requiring…
- TheBrief.Health
Fetal Alcohol Spectrum Disorder (FASD): Understanding Its Lifelong Mental Health Impact
Fetal Alcohol Spectrum Disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, leading to cognitive, behavioral, and mental…
- TheBrief.Health
Narcolepsy Comorbidities and Their Symptom Profiles: What Clinicians and Patients Should Know
Narcolepsy often coexists with psychiatric, respiratory, and metabolic conditions, complicating diagnosis and treatment, requiring comprehensive…
- TheBrief.Health
Big Ideas from the 2026 American Academy of Neurology Annual Meeting (AAN): What’s Changing in Brain Health and Why It Matters
The 2026 American Academy of Neurology Annual Meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, emerging…
- TheBrief.Health
Wrap-Up: Vyvgart Targets Four Populations at AAN 2026
AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent…
- TheBrief.Health
Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP
Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and…
- TheBrief.Health
Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis
At AAN Annual Meeting 2026, efgartigimod alfa showed durable adolescent gMG responses, with 80% achieving minimal symptom expression by cycle two and…
- TheBrief.Health
Pixee Wins FDA Nod For Next-Gen AR Knee Surgery Tech
Pixee Medical’s Knee+ NexSight gains U.S. Food and Drug Administration 510(k) clearance, bringing lightweight AR-guided knee replacement to U.S. operating…
- TheBrief.Health
Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis
At AAN Annual Meeting 2026, ADAPT Jr showed efgartigimod alfa delivered durable adolescent gMG improvements, with 80% achieving minimal symptom expression by…
- TheBrief.Health
Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC
Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over…
- TheBrief.Health
Bridging the Gap: Understanding CMS’ Delay of the BALANCE Model and the Extension of the GLP-1 Bridge
Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over…
- TheBrief.Health
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond…
- TheBrief.Health
Ocular Myasthenia Gravis Gets Its First Targeted Biologic Candidate
New Phase 3 data highlight efgartigimod’s targeted efficacy in ocular myasthenia gravis, signaling a shift toward precision therapies that reduce treatment…
- TheBrief.Health
Vyvgart Crosses the Antibody Line in Seronegative Myasthenia Gravis
Phase 3 ADAPT SERON data show efgartigimod improves function in seronegative generalized myasthenia gravis, with FDA priority review potentially expanding…
- TheBrief.Health
Can Carboplatin Be Safely Omitted in Neoadjuvant HER2-Positive Breast Cancer? Evidence, Patient Selection, and Practice Impact
Reconsidering carboplatin in neoadjuvant HER2-positive breast cancer may reduce toxicity and resource use while maintaining outcomes, emphasizing…
- TheBrief.Health
Sexual Health After Cancer: Why Survivorship Care Must Include Intimacy and Recovery
Sexual health after cancer is often neglected, requiring routine discussion, multidisciplinary care, and better access to support addressing intimacy, body…
- TheBrief.Health
Research Needed for Younger Breast Cancer Survivors’ Progress
Younger breast cancer survivors face unique medical and psychosocial challenges, driving need for targeted research, personalized care plans, and…
- TheBrief.Health
Body Mass Index May Influence Outcomes in Head and Neck Cancer
Overweight BMI in head and neck cancer may be linked to better outcomes, prompting reconsideration of weight’s role in prognosis, treatment planning, and…
- TheBrief.Health
Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis
Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term…
- TheBrief.Health
FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer
Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier…
- TheBrief.Health
Innovating for the Patient: Highlights from the 2026 AAN Annual Meeting
The American Academy of Neurology Annual Meeting 2026 highlighted advances in precision medicine, AI integration, gene therapies, and collaborative approaches…
- TheBrief.Health
The 30-30-30 Diet: An Innovative Approach to Weight Loss
The 30-30-30 diet promotes early protein intake and light exercise to support weight loss, but flexibility and long-term consistency remain key for sustainable…
- TheBrief.Health
Weight Loss Drugs May Risk Bone Health and Malnutrition
Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable…
- TheBrief.Health
Pregabalin vs. Duloxetine: Enhancing Painful Diabetic Neuropathy Care
Combining pregabalin and duloxetine may improve pain control in diabetic neuropathy when monotherapy fails, enabling better symptom relief with lower doses and…
- TheBrief.Health
Understanding Variability in Exercise Response
Individual gut microbiota differences shape metabolic responses to exercise, suggesting personalized activity plans could improve outcomes for patients with…
- TheBrief.Health
FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen
FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and…
- TheBrief.Health
EPA’s Exclusion Of Lives Saved From Pollution Costs Is Misguided
Critics say Environmental Protection Agency cost analyses omit lives saved from cleaner air, potentially weakening regulations, distorting policy decisions…
- TheBrief.Health
Hybrid GI Workforce: Enhancing Clinician Autonomy and Satisfaction
Gastroenterology is shifting to hybrid care models combining in-person and telehealth services, aiming to reduce burnout, improve clinician autonomy, and…
- TheBrief.Health
Tirzepatide May Not Increase Risk of Depression or Suicidal Ideation
Tirzepatide shows no increased risk of depression or suicidal thoughts in trials, supporting its psychological safety and giving clinicians greater confidence…
- TheBrief.Health
While Cancer Mortality Declines in Under-50s, Colorectal Deaths Are Concerning
Cancer deaths are declining among adults under 50, yet rising colorectal cancer mortality in younger groups highlights urgent need for earlier screening…
- TheBrief.Health
Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC): Clinical Outcomes and Recurrence
Early-stage pancreatic cancer care remains challenging after surgery, with growing emphasis on long-term surveillance to detect recurrence earlier, guide…
- TheBrief.Health
Low‑Dose Lithium for Mild Cognitive Impairment: What a Pilot Trial Shows About Safety and Feasibility
Pilot trial shows low-dose lithium in mild cognitive impairment is feasible, informing larger studies while highlighting cautious hope for delaying cognitive…
- TheBrief.Health
The Importance of Mental Health for HCPs: Why Every Shift Needs a Mental Reset for Q2 2026
Healthcare professionals face high stress and burnout, impacting care quality; brief mental resets and supportive workplace cultures improve well-being…
- TheBrief.Health
T-DXd Tolerability in Community-Treated HER2-Low Metastatic Breast Cancer: What Real-World Practice Is Showing
Trastuzumab Deruxtecan is becoming standard for HER2-low metastatic breast cancer, with safe community use requiring careful monitoring, patient education, and…
- TheBrief.Health
The Gap Between Cancer Treatment And Survivorship Support
Cancer survivors often face persistent physical, emotional, and financial challenges after treatment, highlighting gaps in coordinated survivorship care and…
- TheBrief.Health
Ultra‑Hypofractionated Radiation Therapy for Locally Advanced Breast Cancer
Ultra-hypofractionated radiation for locally advanced breast cancer shortens treatment duration, easing patient burden and improving access, while requiring…
- TheBrief.Health
Matched Sibling Donors Remain the Gold Standard for PTCy‑Based Allogeneic Stem Cell Transplantation
Matched sibling donors remain preferred for allogeneic transplantation with PTCy, offering better immune compatibility, fewer complications, and predictable…
- TheBrief.Health
Accountable Care Org Savings: Hard To Measure, Hard To Find
Accountable Care Organizations show modest, uncertain Medicare savings, often influenced by coding, patient selection, and administrative costs, highlighting…
- TheBrief.Health
MiniMed 780G Pump Secures CE Mark With Abbott Instinct Sensor
MiniMed 780G now integrates with Abbott Instinct continuous glucose monitor, expanding sensor choice, improving flexibility, and advancing interoperability in…
- TheBrief.Health
Blood Pressure Metric Could Help Predict Dementia Risk
Emerging blood pressure metrics, including variability and vascular aging signals, may help predict dementia risk earlier, enabling proactive prevention…
- TheBrief.Health
FDA Approves Avlayah In Hunter Syndrome Neurologic Manifestations
FDA approved Avlayah for pediatric Hunter syndrome, delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve…
- TheBrief.Health
State Spending Growth Benchmarks & Hospital Revenue
State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better…
- TheBrief.Health
IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and…
- TheBrief.Health
Early, Personalized Cholesterol Screening and LDL-Lowering: What the New Guidelines Mean for Clinicians, Patients, and Payers
New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like…
- TheBrief.Health
Psilocybin-Assisted Therapy: Promise, Safety, and the Path to Clinical Adoption
Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory…
- TheBrief.Health
Budgetary Impact Of The MSSP On Traditional Medicare
Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs…
- TheBrief.Health
Ketamine-Assisted MORE For Opioid Use Disorder: RCT
Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but…
- TheBrief.Health
Catheter Extraction Of Right-Sided IE Without Surgery
Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk…
- TheBrief.Health
AI, 3D Body-Volume Scan Improve Metabolic Syndrome Risk Precision
AI-enhanced 3D body scans improve metabolic syndrome risk detection beyond BMI by capturing fat distribution, enabling earlier, personalized interventions…
- TheBrief.Health
Best Late-Line Treatments for Metastatic Colorectal Cancer
In metastatic colorectal cancer, late-line therapy choices balance survival, toxicity, and convenience; SUNLIGHT data suggest neutropenia may signal effective…
- TheBrief.Health
THP Noninferior To TCbHP For pCR In HER2+ Early Breast Cancer
THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy…
- TheBrief.Health
Phase 2b Biomarker Analysis: BCMA CAR-T in Myasthenia Gravis
BCMA-directed CAR-T therapy shows promise in myasthenia gravis by selectively targeting plasma cells, improving outcomes, and prompting biomarker-guided care…
- TheBrief.Health
MIND Diet Adherence Linked to Slower Structural Brain Atrophy
MIND diet adherence may slow brain atrophy and cognitive decline, encouraging clinicians and policymakers to integrate preventive nutrition counseling, expand…